XML 17 R6.htm IDEA: XBRL DOCUMENT v3.4.0.3
Condensed Consolidated Statements of Cash Flows - USD ($)
 3 Months Ended
Mar. 31, 2016
Mar. 31, 2015
Cash flows from operating activities:    
Net loss $ (535,765) $ (208,857)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 2,956 3,378
Bad debt expense 0 18,082
Amortization of deferred financing costs 708 3,879
Amortization of beneficial conversion option 0 26,767
Stock issued for services 62,500 0
Stock options compensation 67,193 0
Note conversion warrant expense 137,970 0
Changes in operating assets and liabilities:    
Accounts receivable (54,295) (145,318)
Prepaid expenses and other current assets (29,579) 14,858
Accounts payable and accrued expenses (68,489) 57,130
Other long-term liabilities - related parties (12,852) 34,242
Deferred interest expense 8,198 9,613
Deferred revenues (127,506) (62,523)
Total adjustments (13,196) (39,892)
Net cash used in operating activities (548,961) (248,749)
Cash flows from investing activities:    
Purchases of property and equipment 0 0
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Sale of Common Stock 559,285 0
Exercise of stock options 3,500 0
Proceeds from notes payable - related parties 0 200,000
Repayment of notes payable (60,000) (48,000)
Repayment of notes payable - related parties (66,501) (7,557)
Net cash provided by financing activities 436,284 144,443
Net decrease in cash (112,677) (104,306)
Cash - beginning of period 1,117,118 184,081
Cash - end of period 1,004,441 79,775
Supplemental disclosure of cash flow information:    
Cash paid during the period for interest and taxes 20,294 11,479
Supplemental disclosure of non-cash financing activities:    
Accrued interest on notes payable converted to equity 35,038 0
Notes payable conversion warrant expense 113,762 0
Note payable conversion underwriting warrant expense 24,207 0
Notes payable converted to equity $ 135,000 $ 0